SKK
ACER

Shepherd Kaplan Krochuk’s Acer Therapeutics Inc ACER Stock Holding History

Shepherd Kaplan Krochuk’s Portfolio ACER Stock Details ACER Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-1,198
Closed -$99K – 566
2014
Q3 		$99K Sell
1,198
-198
-14% -$23.5K 0.01% 495
2014
Q2 		$193K Buy
1,396
+226
+19% +$29.9K 0.02% 448
2014
Q1 		$182K Buy
1,170
+264
+29% +$40.1K 0.02% 470
2013
Q4 		$137K Buy
906
+96
+12% +$15.6K 0.02% 473
2013
Q3 		$148K Buy
810
+72
+10% +$9.62K 0.02% 472
2013
Q2 		$94K Buy
+738
New +$108K 0.02% 523

Other funds holding ACER

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VKH
Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return
MC
Moors & Cabot Boston, Massachusetts $2.34B AUM 30.42% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return

Shepherd Kaplan Krochuk's ACER Position: Q4 2014 in Review

Shepherd Kaplan Krochuk sold out of Acer Therapeutics Inc (ACER) in Q4 2014, closing a stake of 1,198 shares — an estimated $99K sold.

Shepherd Kaplan Krochuk first reported a position in ACER in Q2 2013 and held it in 6 quarters. The position peaked at $193K in Q2 2014. 16 funds tracked by Wall St. Rank hold ACER as of Q4 2014.

  • Shepherd Kaplan Krochuk reported no remaining Acer Therapeutics Inc position as of Q4 2014 after selling out during the quarter.
  • Shepherd Kaplan Krochuk sold 1,198 Acer Therapeutics Inc shares in Q4 2014, an estimated $99K.
  • Shepherd Kaplan Krochuk first reported a position in Acer Therapeutics Inc in Q2 2013 and held it in 6 quarters.
  • Shepherd Kaplan Krochuk's Acer Therapeutics Inc position peaked at $193K in Q2 2014.
  • 16 funds tracked by Wall St. Rank held Acer Therapeutics Inc as of Q4 2014.

Based on Shepherd Kaplan Krochuk's 13F filing for Q4 2014, filed 17 Feb 2015.